Mario Mancino

3.7k total citations · 1 hit paper
34 papers, 2.8k citations indexed

About

Mario Mancino is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mario Mancino has authored 34 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Mario Mancino's work include Cancer Cells and Metastasis (7 papers), HER2/EGFR in Cancer Research (7 papers) and TGF-β signaling in diseases (5 papers). Mario Mancino is often cited by papers focused on Cancer Cells and Metastasis (7 papers), HER2/EGFR in Cancer Research (7 papers) and TGF-β signaling in diseases (5 papers). Mario Mancino collaborates with scholars based in Italy, United States and Spain. Mario Mancino's co-authors include Caterina Bianco, Luigi Strizzi, Nicola Normanno, Antonella De Luca, Monica R. Maiello, David Salomon, Francesco Caponigro, Gianfranco De Feo, Vanessa Almendro and Pedro Gascón and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and The Lancet Oncology.

In The Last Decade

Mario Mancino

31 papers receiving 2.7k citations

Hit Papers

Epidermal growth factor receptor (EGFR) signaling in cancer 2005 2026 2012 2019 2005 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Epidermal growth factor receptor (EGFR) signaling in cancer
    2005 1.6k citations Nicola Normanno, Antonella De Luca et al. Gene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Mancino Italy 19 1.6k 1.2k 570 341 286 34 2.8k
Oliver M. Fischer Germany 16 1.4k 0.9× 1.1k 0.8× 377 0.7× 305 0.9× 359 1.3× 25 2.8k
Andreas Gschwind Germany 9 1.6k 1.0× 1.1k 0.9× 294 0.5× 311 0.9× 383 1.3× 10 2.7k
Stefan Hart Singapore 23 1.4k 0.9× 1.0k 0.8× 273 0.5× 263 0.8× 211 0.7× 30 2.7k
Yibing Yan United States 29 2.2k 1.4× 1.9k 1.5× 462 0.8× 437 1.3× 283 1.0× 85 3.9k
József Tóvári Hungary 29 1.7k 1.1× 1.1k 0.9× 395 0.7× 613 1.8× 146 0.5× 143 3.1k
Geoffrey Bartholomeusz United States 24 2.0k 1.3× 1.1k 0.9× 542 1.0× 482 1.4× 234 0.8× 45 3.1k
Juan Carlos Montero Spain 31 1.7k 1.1× 1.1k 0.9× 233 0.4× 376 1.1× 332 1.2× 90 2.8k
Jennifer L. Stamos United States 14 2.2k 1.4× 788 0.6× 370 0.6× 210 0.6× 258 0.9× 17 3.3k
Jacek Pinski United States 31 1.1k 0.7× 727 0.6× 1.1k 2.0× 415 1.2× 359 1.3× 114 2.9k
Ruoxiang Wang United States 35 1.6k 1.0× 1.1k 0.9× 904 1.6× 777 2.3× 146 0.5× 86 3.2k

Countries citing papers authored by Mario Mancino

Since Specialization
Citations

This map shows the geographic impact of Mario Mancino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Mancino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Mancino more than expected).

Fields of papers citing papers by Mario Mancino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Mancino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Mancino. The network helps show where Mario Mancino may publish in the future.

Co-authorship network of co-authors of Mario Mancino

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Mancino. A scholar is included among the top collaborators of Mario Mancino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Mancino. Mario Mancino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Quintás‐Cardama, Alfonso, Daniel Martı́nez, Sara Marín, et al.. (2025). Abstract 5799: The immune and metabolic profile in the response to neoadjuvant treatment with immune checkpoint inhibitors in triple-negative breast cancer patients. Cancer Research. 85(8_Supplement_1). 5799–5799.
3.
Llombart‐Cussac, Antonio, Fara Brasó‐Maristany, Laia Paré, et al.. (2024). HER2DX Genomic Assay in HER2-Positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from the PHERGain Phase II Trial. Clinical Cancer Research. 30(18). 4123–4130. 5 indexed citations
4.
5.
Llombart‐Cussac, Antonio, José Manuel Pérez-García, Peter Schmid, et al.. (2023). 150P Validation of a genomic assay in early-stage HER2+ breast cancer (BC) treated with trastuzumab and pertuzumab (HP): A correlative analysis from PHERGain phase II trial. Annals of Oncology. 34. S240–S241.
6.
Fernández‐Nogueira, Patricia, Gemma Fuster, Patricia Jáuregui, et al.. (2018). Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer. Cancer Letters. 424. 70–83. 43 indexed citations
7.
Mancino, Mario, Patricia Fernández‐Nogueira, Neus Carbó, et al.. (2018). Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis. Breast Cancer Research. 20(1). 65–65. 8 indexed citations
8.
Ametller, Elisabet, et al.. (2015). Comparison of methods for the isolation of human breast epithelial and myoepithelial cells. Frontiers in Cell and Developmental Biology. 3. 32–32. 23 indexed citations
9.
Bianco, Caterina, Enza Lonardo, Luigi Strizzi, et al.. (2009). Cripto-1 Is Required for Hypoxia to Induce Cardiac Differentiation of Mouse Embryonic Stem Cells. American Journal Of Pathology. 175(5). 2146–2158. 47 indexed citations
10.
Bianco, Caterina, Luigi Strizzi, Mario Mancino, et al.. (2008). Regulation of Cripto-1 Signaling and Biological Activity by Caveolin-1 in Mammary Epithelial Cells. American Journal Of Pathology. 172(2). 345–357. 17 indexed citations
11.
Hirota, Morihisa, Kazuhide Watanabe, Shin Hamada, et al.. (2008). Smad2 functions as a co-activator of canonical Wnt/β-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300. Cellular Signalling. 20(9). 1632–1641. 47 indexed citations
12.
Strizzi, Luigi, Mario Mancino, Caterina Bianco, et al.. (2008). Netrin‐1 can affect morphogenesis and differentiation of the mouse mammary gland. Journal of Cellular Physiology. 216(3). 824–834. 22 indexed citations
13.
Bianco, Caterina, Kazuhide Watanabe, Mario Mancino, et al.. (2008). Activation of a Nodal‐independent signaling pathway by Cripto‐1 mutants with impaired activation of a Nodal‐dependent signaling pathway. FEBS Letters. 582(29). 3997–4002. 9 indexed citations
14.
Normanno, Nicola, Manuela Campiglio, Monica R. Maiello, et al.. (2007). Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling. Breast Cancer Research and Treatment. 112(1). 25–33. 42 indexed citations
15.
Watanabe, Kazuhide, Shin Hamada, Caterina Bianco, et al.. (2007). Requirement of Glycosylphosphatidylinositol Anchor of Cripto-1 for trans Activity as a Nodal Co-receptor. Journal of Biological Chemistry. 282(49). 35772–35786. 48 indexed citations
16.
Normanno, Nicola, Antonella De Luca, Monica R. Maiello, et al.. (2006). The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. Journal of Cellular Physiology. 207(2). 420–427. 119 indexed citations
17.
Normanno, Nicola, Antonella De Luca, Caterina Bianco, et al.. (2005). Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 366(1). 2–16. 1576 indexed citations breakdown →
18.
Normanno, Nicola, Caterina Bianco, Luigi Strizzi, et al.. (2005). The ErbB Receptors and their Ligands in Cancer: An Overview. Current Drug Targets. 6(3). 243–257. 225 indexed citations
19.
Normanno, Nicola, Antonella De Luca, Monica R. Maiello, et al.. (2004). CRIPTO-1: a novel target for therapeutic intervention in human carcinoma.. International Journal of Oncology. 25(4). 1013–1033. 22 indexed citations
20.
Normanno, Nicola, Monica R. Maiello, Mario Mancino, & Antonella De Luca. (2004). Small Molecule Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: An Overview. Journal of Chemotherapy. 16(sup4). 36–40. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver M. Fischer Breakdown of academic impact, for papers by Andreas Gschwind Breakdown of academic impact, for papers by Stefan Hart Breakdown of academic impact, for papers by Yibing Yan Breakdown of academic impact, for papers by József Tóvári Breakdown of academic impact, for papers by Geoffrey Bartholomeusz Breakdown of academic impact, for papers by Juan Carlos Montero Breakdown of academic impact, for papers by Jennifer L. Stamos Breakdown of academic impact, for papers by Jacek Pinski Breakdown of academic impact, for papers by Ruoxiang Wang
Rankless by CCL
2026